- Intended Use: For laboratory research use only
- GLP3-R (often called Retatrutide) is a novel, investigational triple-hormone agonist currently in Phase 3 clinical trials for weight loss and type 2 diabetes.
Note: Not for human or veterinary use. For in-vitro research only.









